Available projects
Applications are invited from 31 October - 9 December 2022
| ID | Title | Internal supervisors | Phase |
|---|---|---|---|
| #OxKEN-2023/1 #OxKEN-2023/1 | Influence of Modifiable factors in PsA contributing to treat to target success (the IMPACT study) Influence of Modifiable factors in PsA contributing to treat to target success (the IMPACT study) | Laura Coates | OxKEN 2023 |
| #OxKEN-2023/2 #OxKEN-2023/2 | Elucidating T cell phenotype and function in frozen shoulder Elucidating T cell phenotype and function in frozen shoulder | Stephanie Dakin, Christopher Buckley, Mark Coles | OxKEN 2023 |
| #OxKEN-2023/3 #OxKEN-2023/3 | Co-prevalence of liver disease in psoriatic disease (COLIPSO) Co-prevalence of liver disease in psoriatic disease (COLIPSO) | Laura Coates, Hussein Al-Mossawi | OxKEN 2023 |
| #OxKEN-2023/4 #OxKEN-2023/4 | Understanding and exploiting antigen discrimination by T cells Understanding and exploiting antigen discrimination by T cells | OxKEN 2023 | |
| #OxKEN-2023/5 #OxKEN-2023/5 | Gamma-delta intra-epithelial lymphocytes in coeliac disease Gamma-delta intra-epithelial lymphocytes in coeliac disease | OxKEN 2023 | |
| #OxKEN-2023/6 #OxKEN-2023/6 | Investigating the role of neutrophil subsets in vascular inflammation Investigating the role of neutrophil subsets in vascular inflammation | Irina Udalova, Raashid Luqmani, Kristina Zec | OxKEN 2023 |
| #OxKEN-2023/7 #OxKEN-2023/7 | Investigating interactions between oxygen-sensing pathways and autoimmunity Investigating interactions between oxygen-sensing pathways and autoimmunity | OxKEN 2023 | |
| #OxKEN-2023/8 #OxKEN-2023/8 | Form meets function in synovium: Did the evolution of power and precision grip drive development of rheumatoid arthritis? Form meets function in synovium: Did the evolution of power and precision grip drive development of rheumatoid arthritis? | Mark Coles, Christopher Buckley | OxKEN 2023 |
| #OxKEN-2023/9 #OxKEN-2023/9 | Identifying therapeutic combinations for immune mediated inflammatory disease using computational modelling, artificial intelligence and experimentation Identifying therapeutic combinations for immune mediated inflammatory disease using computational modelling, artificial intelligence and experimentation | Mark Coles | OxKEN 2023 |
| #OxKEN-2023/10 #OxKEN-2023/10 | Towards equity in medicine with big health data, epidemiology, and Artificial intelligence Towards equity in medicine with big health data, epidemiology, and Artificial intelligence | Daniel Prieto-Alhambra, Sara Khalid, Antonella Delmestri, Laura Coates, Gary Collins | OxKEN 2023 |
| #OxKEN-2023/11 #OxKEN-2023/11 | Developing and testing a humanised mouse model of fibrosis Developing and testing a humanised mouse model of fibrosis | Dominic Furniss | OxKEN 2023 |
| #OxKEN-2023/12 #OxKEN-2023/12 | Investigation of DDR2 signalling that promotes synovial cell invasion into cartilage in rheumatoid arthritis Investigation of DDR2 signalling that promotes synovial cell invasion into cartilage in rheumatoid arthritis | Yoshi Itoh, Christopher Buckley, Richard Williams | OxKEN 2023 |
| #OxKEN-2023/13 #OxKEN-2023/13 | Characterizing the ageing phenotype of fibroblast populations in the synovium of RA and OA patients Characterizing the ageing phenotype of fibroblast populations in the synovium of RA and OA patients | Ghada Alsaleh, Tonia Vincent, Christopher Buckley | OxKEN 2023 |
| #OxKEN-2023/14 #OxKEN-2023/14 | Autoantigen keratin-17 as a key driver of anterior uveitis Autoantigen keratin-17 as a key driver of anterior uveitis | Christopher Buckley, Lakshanie Wickramasinghe | OxKEN 2023 |
| #OxKEN-2023/15 #OxKEN-2023/15 | A cellular atlas of the human hip to understand the relationship between femeroacetabular impingement and hip osteoarthritis A cellular atlas of the human hip to understand the relationship between femeroacetabular impingement and hip osteoarthritis | Sarah Snelling, Mathew Baldwin, Adam Cribbs, Philippa Hulley | OxKEN 2023 |
| #OxKEN-2023/16 #OxKEN-2023/16 | Spatial exploration of hypoxic signalling and inflammation in chronic hepatitis B. Spatial exploration of hypoxic signalling and inflammation in chronic hepatitis B. | OxKEN 2023 | |
| #OxKEN-2023/17 #OxKEN-2023/17 | Establishing the Insulin-like growth factor 1 (IGF-1) axis as a therapeutic target in carpal tunnel syndrome and trigger finger Establishing the Insulin-like growth factor 1 (IGF-1) axis as a therapeutic target in carpal tunnel syndrome and trigger finger | Dominic Furniss, Tonia Vincent, Akira Wiberg | OxKEN 2023 |
| #OxKEN-2023/18 #OxKEN-2023/18 | Matrix architecture in the perivascular niche: a master regulator of lymphocyte infiltration in inflammatory disease? Matrix architecture in the perivascular niche: a master regulator of lymphocyte infiltration in inflammatory disease? | Kim Midwood, Fiona Powrie FRS | OxKEN 2023 |
| #OxKEN-2023/19 #OxKEN-2023/19 | The dark side of hypoferremia: does iron deficiency disable innate immunity in humans? The dark side of hypoferremia: does iron deficiency disable innate immunity in humans? | James Fullerton | OxKEN 2023 |
| #OxKEN-2023/20 #OxKEN-2023/20 | A clinically-relevant musculoskeletal humanoid shoulder for studying joint instabilities and diseases A clinically-relevant musculoskeletal humanoid shoulder for studying joint instabilities and diseases | Pierre-Alexis Mouthuy, Julie Stebbins, Steve Gwilym | OxKEN 2023 |
| #OxKEN-2023/21 #OxKEN-2023/21 | Epigenetic targeting of fibroblasts as a novel therapeutic avenue for fibro-stenotic Crohn’s disease Epigenetic targeting of fibroblasts as a novel therapeutic avenue for fibro-stenotic Crohn’s disease | OxKEN 2023 | |
| #OxKEN-2023/22 #OxKEN-2023/22 | Interrogating immune-mediated inflammatory disease via cutaneous human immune challenge Interrogating immune-mediated inflammatory disease via cutaneous human immune challenge | James Fullerton, Christopher Buckley | OxKEN 2023 |
| #OxKEN-2023/23 #OxKEN-2023/23 | Developmental engineering models of skeletal ciliopathies. Developmental engineering models of skeletal ciliopathies. | Angus Wann, Tonia Vincent | OxKEN 2023 |